News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Our PCORI-funded CDK study has officially enrolled its first patient at Ironwood Cancer Center – ASCO
ASCO/X
Dec 20, 2024, 17:25

Our PCORI-funded CDK study has officially enrolled its first patient at Ironwood Cancer Center – ASCO

ASCO made the following post on X:

“Exciting news! Our PCORI-funded CDK study has officially enrolled its first patient at Ironwood Cancer Center. This is a major step forward in improving dosing strategies for older adults with metastatic breast cancer.

Learn more.”

ASCO cancer CDK Study Ironwood Cancer Center metastatic breast cancer older adults OncoDaily Oncology PCORI
Special Coverage
Blog
Jun 20, 2025, 03:55
Nicolas Hart: Presenting on Cancer Survivorship at Wolper Jewish Hospital
Drugs
Jun 20, 2025, 02:19
Is Tamoxifen Chemotherapy? Understanding Its Role in Breast Cancer Treatment
Blog
Jun 19, 2025, 17:36
ESTRO Introduces KAYAC+ to Advance Radiation Therapy For Adolescents And Young Adults With Cancer
Blog
Jun 19, 2025, 17:26
XVII CCI LATAM Conference Was a Celebration Of a Growing Community, Unity, and Hope - Childhood Cancer International
Blog
Jun 19, 2025, 17:07
Join The AI For Everyone, Everywhere, Let’s talk about Large Language Models Meeting - SIOP
Blog
Jun 19, 2025, 16:57
David Planchard: We Need to Work Together to Develop The Wave of New Treatments That Is Coming For Our Patients
Blog
Jun 19, 2025, 16:21
Neeraj Agarwal: Poor Outcomes with SOC in mHSPC Prostate Cancer Patients With HRR Mutation
Blog
Jun 19, 2025, 16:12
World Kidney Cancer Day 2025: Uniting for Progress in the Fight Against Renal Cell Carcinoma
Blog
Jun 19, 2025, 16:01
IARC Marks World Kidney Cancer Day with New Video and Project Highlights
Science
Jun 19, 2025, 15:50
Alexey Kulikov Shared An Article on Cancer Vaccines and The Future of Immunotherapy
Opinion
Jun 19, 2025, 15:47
Mostafa Faisal: Primary Refractory AML and Allo-HCT - A 10-Year Retrospective Study from Japan
Blog
Jun 19, 2025, 15:36
Amol Akhade: KEYNOTE-689 - A Turning Point in Resectable HNSCC - Or a Cautious Step Forward?